AOD-9604
Also known as: HGH Fragment 176-191
limited human dataWADA bannedNot FDA approvedResearch only
Published Dose Range
Low200 mcg/day
Typical200-500 mcg/day
High500 mcg/day
Beyond 500 mcg/day shows no additional benefit. Morning preferred.
Published Cycle Range
Short4 wks
Typical8 wks
Long12 wks
4-12 weeks. 2-4 week break between cycles. Results appear after 6-8 weeks.
Off-cycle: 3 weeks
Administration
Routessubcutaneous
FrequencyOnce daily (or split AM/PM)
Preferred timingMorning fasted (fat mobilization)
Abdominal injection preferred
Safety Profile
Common side effects
- • Injection site irritation
- • Mild fatigue
- • Headache
Pregnancy / breastfeeding
No data — consult clinician
Common Misconceptions
- Does not raise IGF-1 or affect blood sugar — safer profile than full HGH
- Less potent than GLP-1 agonists for fat loss
- Fragment identity inconsistent in literature (176-191 vs 177-191)
Commonly Stacked With
CJC-1295 + IpamorelinBPC-157TB-500
Next Steps
Sign in to calculate your dose, add this compound to your stack, and check for interactions with your current cabinet.